Manufacturing

Articles

Ori Biotech is partnering with manufacturers and materials suppliers to develop an automated system for cell and gene therapy manufacturing. 

Ori Biotech and CellGenix Collaborate on Closed-system, Cell and Gene Therapy Manufacturing

Synthetic depth filters are a suitable option to provide a high-performance and scalable single-step clarification process.

Optimizing Viral Vector Manufacturing for Gene Therapy

The company will invest $180 million to construct a new 290,000-ft2 facility in Plainville, MA.

Thermo Fisher Scientific to Double Viral Vector Manufacturing Capacity

Hitachi Chemical Advanced Therapeutics Solutions and apceth Biopharma entered into long-term development and manufacturing services agreements for the clinical and commercial supply of multiple bluebird bio therapies.

HCATS, apceth Biopharma Form Strategic Manufacturing Agreements with bluebird bio

The center will be located at NJIT’s Life Sciences and Engineering center and will feature two good manufacturing practices suites that are expected to be completed and operational during the summer of 2020. 

NJII Launches Cell and Gene Therapy Manufacturing Center

The new cell-line producing platform enables fully scalable production of high-performance adeno-associated virus vectors.

Cevec Launches ELEVECTA Platform for AAV Vectors for Gene Therapy

The company will build an additional commercial-scale, contract manufacturing facility for viral vectors and gene therapies near its existing site in Carlsbad, CA.

MilliporeSigma Adds Viral Vector and Gene Therapy Capacity


Daiichi Sankyo has entered into a partnership with Ultragenyx Pharmaceutical for the use of Ultragenyx’s proprietary AAV-based gene-therapy manufacturing technology.


Daiichi Sankyo Enters Partnership with Ultragenyx for a Total of $225 Million

The new patented process results in uniform, scalable production and the ability to deliver cell cargo similar to natural exosomes/extracellular vesicles.

Orgenesis, ExcellaBio Announce Breakthrough Manufacturing Process for Bioxomes

Thermo Fisher is focused on investing to expand three specific areas of demand: biologics, cell and gene therapy, and drug product development and commercial capabilities.

Manufacturing, Gene Therapies